1 active not recruiting, 1 completed, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Desmoid Tumor: new trials by email Literature Review of Desmoid Tumor trials Research Report on Desmoid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AL102 in Patients With Progressing Desmoid Tumors AL102, Placebo - Desmoid, Desmoid Tumor | Phase 2 / Phase 3 | Active not recruiting | Immunome, Inc. | 198 | 2021-09-01 | 2026-06-08 |
| A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor Liposome doxorubicin, Saline Solution - Desmoid Tumor | Phase 3 | Unknown | Sun Yat-sen University | 72 | 2020-09-29 | 2022-09-30 |
| Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) Nirogacestat oral tablet, Placebo Oral Tablet - Desmoid Tumor, Aggressive Fibromatosis | Phase 3 | Completed | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 142 | 2019-04-17 | 2026-08-20 |
Desmoid Tumors (3)
Fibroma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Connective Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Neoplasms, Fibrous Tissue (3)
Saline Solution (1) · nirogacestat (1)
Immunome, Inc. (1) · SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1) · Sun Yat-sen University (1)
Belgium (2) · Germany (2) · Italy (2) · Netherlands (2) · United Kingdom (2) · United States (2) · Australia (1) · Canada (1) · China (1) · Israel (1) · Poland (1) · South Korea (1) · Spain (1)
Bernd Kasper, MD (1) · Mrinal Gounder, MD (1)